Axsome Therapeutics Earnings
NASDAQ: AXSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$-0.59
Axsome Therapeutics earnings summary
Axsome Therapeutics is scheduled to report Sep/2026 earnings on Nov 2, 2026 before the market opens, with analysts expecting EPS of $-0.59. In its most recent report on Aug 10, 2026 (Q2 2026), AXSM posted EPS of $-0.99. Revenue for the quarter was $218.4 million.
Across the last 16 reports, AXSM shares moved an average of 4.2% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
AXSM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.99 | — | -2.8% |
| May 4, 2026 | — | $-1.26 | — | +4.8% |
| Feb 23, 2026 | — | $-0.55 | — | -1.0% |
| Nov 3, 2025 | — | $-0.94 | — | +1.1% |
| Aug 4, 2025 | — | $-0.97 | — | +4.2% |
| May 5, 2025 | — | $-1.22 | — | -0.2% |
| Feb 18, 2025 | — | $-1.54 | — | -7.4% |
| Nov 12, 2024 | — | $-1.34 | — | +5.9% |
| Aug 5, 2024 | — | $-1.67 | — | +3.7% |
| May 6, 2024 | — | $-1.44 | — | +5.6% |
| Feb 23, 2024 | — | $-2.15 | — | +4.4% |
| Nov 6, 2023 | — | $-1.32 | — | +4.3% |
| Aug 7, 2023 | — | $-1.54 | — | +1.7% |
| May 9, 2023 | — | $-0.26 | — | -4.2% |
| Feb 28, 2023 | — | $-1.41 | — | -10.6% |
| Nov 7, 2022 | — | $-1.07 | — | -4.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.